APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Liganlong Granules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Liganlong Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174007600329 December 2025197 pages

Choose your research edition.

Industry ResearchLiganlong Granules Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Liganlong Granules Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Liganlong Granules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liganlong Granules Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Liganlong Granules Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Liganlong Granules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Liganlong Granules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Liganlong Granules include Zhongjing Wanxi Pharmaceutical Co., Ltd., Tibet Tibetan Medicine Group Co., Ltd., Sichuan Luye Pharmaceutical Co., Ltd., Liaoning Wohua Kangchen Pharmaceutical Co., Ltd., Liaoning Keji Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd., Jiangxi Chuanqi Pharmaceutical Co., Ltd., Jilin Yatai Pharmaceutical Co., Ltd. and Jilin Yinoke Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Liganlong Granules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liganlong Granules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liganlong Granules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Liganlong Granules market size, projected growth trends, production technologies, key applications, and end-use industries.

Liganlong Granules Segment by Company

Zhongjing Wanxi Pharmaceutical Co., Ltd.

Tibet Tibetan Medicine Group Co., Ltd.

Sichuan Luye Pharmaceutical Co., Ltd.

Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.

Liaoning Keji Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jiangxi Chuanqi Pharmaceutical Co., Ltd.

Jilin Yatai Pharmaceutical Co., Ltd.

Jilin Yinoke Pharmaceutical Co., Ltd.

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Heilongjiang Tianhong Pharmaceutical Co., Ltd.

Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.

Hainan Zhongbao Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Guizhou Dalong Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.

Guangxi Xiuzhen Pharmaceutical Co., Ltd.

Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.

Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.

Dalian Meiluo Chinese Medicine Factory Co., Ltd.

Dalian Hanfang Pharmaceutical Co., Ltd.

Liganlong Granules Segment by Type

5g

10g

Liganlong Granules Segment by Application

Hospital

Clinic

Other

Liganlong Granules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liganlong Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liganlong Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liganlong Granules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Liganlong Granules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Liganlong Granules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Liganlong Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Liganlong Granules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Liganlong Granules Industry Trends Table 2. Liganlong Granules Industry Drivers Table 3. Liganlong Granules Industry Opportunities and Challenges Table 4. Liganlong Granules Industry Restraints Table 5. Global Liganlong Granules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Liganlong Granules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Liganlong Granules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Liganlong Granules Sales Market Share by Manufacturers Table 9. Global Liganlong Granules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Liganlong Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Liganlong Granules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Liganlong Granules Manufacturers, Product Type & Application Table 13. Global Liganlong Granules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Liganlong Granules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5g Table 17. Major Manufacturers of 10g Table 18. Global Liganlong Granules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Liganlong Granules Sales by Type (2021-2026) & (K Units) Table 20. Global Liganlong Granules Sales by Type (2027-2032) & (K Units) Table 21. Global Liganlong Granules Sales Market Share by Type (2021-2026) Table 22. Global Liganlong Granules Sales Market Share by Type (2027-2032) Table 23. Global Liganlong Granules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Liganlong Granules Revenue by Type (2021-2026) & (K Units) Table 25. Global Liganlong Granules Revenue by Type (2027-2032) & (K Units) Table 26. Global Liganlong Granules Revenue Market Share by Type (2021-2026) Table 27. Global Liganlong Granules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Major Manufacturers of Other Table 31. Global Liganlong Granules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Liganlong Granules Sales by Application (2021-2026) & (K Units) Table 33. Global Liganlong Granules Sales by Application (2027-2032) & (K Units) Table 34. Global Liganlong Granules Sales Market Share by Application (2021-2026) Table 35. Global Liganlong Granules Sales Market Share by Application (2027-2032) Table 36. Global Liganlong Granules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Liganlong Granules Revenue by Application (2021-2026) & (K Units) Table 38. Global Liganlong Granules Revenue by Application (2027-2032) & (K Units) Table 39. Global Liganlong Granules Revenue Market Share by Application (2021-2026) Table 40. Global Liganlong Granules Revenue Market Share by Application (2027-2032) Table 41. Global Liganlong Granules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Liganlong Granules Sales by Region (2021-2026) & (K Units) Table 43. Global Liganlong Granules Sales Market Share by Region (2021-2026) Table 44. Global Liganlong Granules Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Liganlong Granules Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Liganlong Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 48. North America Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 49. Europe Liganlong Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 51. Europe Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Liganlong Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Liganlong Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Liganlong Granules Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Liganlong Granules Sales by Country (2027-2032) & (K Units) Table 58. Global Liganlong Granules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Liganlong Granules Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Liganlong Granules Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Liganlong Granules Revenue Market Share by Region (2021-2026) Table 62. Global Liganlong Granules Revenue Market Share by Region (2027-2032) Table 63. Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information Table 64. Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview Table 65. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 67. Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Development Table 68. Tibet Tibetan Medicine Group Co., Ltd. Company Information Table 69. Tibet Tibetan Medicine Group Co., Ltd. Business Overview Table 70. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio Table 72. Tibet Tibetan Medicine Group Co., Ltd. Recent Development Table 73. Sichuan Luye Pharmaceutical Co., Ltd. Company Information Table 74. Sichuan Luye Pharmaceutical Co., Ltd. Business Overview Table 75. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 77. Sichuan Luye Pharmaceutical Co., Ltd. Recent Development Table 78. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information Table 79. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview Table 80. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 82. Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Development Table 83. Liaoning Keji Pharmaceutical Co., Ltd. Company Information Table 84. Liaoning Keji Pharmaceutical Co., Ltd. Business Overview Table 85. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 87. Liaoning Keji Pharmaceutical Co., Ltd. Recent Development Table 88. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 89. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 90. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 92. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Development Table 93. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information Table 94. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview Table 95. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 97. Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Development Table 98. Jilin Yatai Pharmaceutical Co., Ltd. Company Information Table 99. Jilin Yatai Pharmaceutical Co., Ltd. Business Overview Table 100. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 102. Jilin Yatai Pharmaceutical Co., Ltd. Recent Development Table 103. Jilin Yinoke Pharmaceutical Co., Ltd. Company Information Table 104. Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview Table 105. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 107. Jilin Yinoke Pharmaceutical Co., Ltd. Recent Development Table 108. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information Table 109. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview Table 110. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 112. Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Development Table 113. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information Table 114. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview Table 115. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 117. Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Development Table 118. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information Table 119. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview Table 120. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 122. Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Development Table 123. Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information Table 124. Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview Table 125. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 127. Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Development Table 128. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 129. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 130. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 132. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Development Table 133. Guizhou Dalong Pharmaceutical Co., Ltd. Company Information Table 134. Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview Table 135. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 137. Guizhou Dalong Pharmaceutical Co., Ltd. Recent Development Table 138. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information Table 139. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview Table 140. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 142. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Development Table 143. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information Table 144. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview Table 145. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 147. Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Development Table 148. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information Table 149. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview Table 150. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 152. Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Development Table 153. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information Table 154. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview Table 155. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio Table 157. Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Development Table 158. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information Table 159. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview Table 160. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio Table 162. Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Development Table 163. Dalian Hanfang Pharmaceutical Co., Ltd. Company Information Table 164. Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview Table 165. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio Table 167. Dalian Hanfang Pharmaceutical Co., Ltd. Recent Development Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Liganlong Granules Distributors List Table 171. Liganlong Granules Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Liganlong Granules Product Image Figure 2. Global Liganlong Granules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liganlong Granules Market Size (2021-2032) & (US$ Million) Figure 4. Global Liganlong Granules Sales (2021-2032) & (K Units) Figure 5. Global Liganlong Granules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Liganlong Granules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5g Image Figure 9. 10g Image Figure 10. Global Liganlong Granules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Liganlong Granules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Liganlong Granules Sales Market Share by Type (2021-2032) Figure 13. Global Liganlong Granules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Liganlong Granules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Liganlong Granules Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Other Image Figure 19. Global Liganlong Granules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Liganlong Granules Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Liganlong Granules Sales Market Share by Application (2021-2032) Figure 22. Global Liganlong Granules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Liganlong Granules Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Liganlong Granules Revenue Market Share by Application (2021-2032) Figure 25. North America Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Liganlong Granules Sales Market Share by Country (2021-2032) Figure 27. U.S. Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Liganlong Granules Sales Market Share by Country (2021-2032) Figure 32. Germany Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Liganlong Granules Sales Market Share by Country (2021-2032) Figure 39. China Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Liganlong Granules Sales Market Share by Country (2021-2032) Figure 47. Brazil Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Liganlong Granules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Liganlong Granules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Liganlong Granules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Liganlong Granules Revenue (2021-2032) & (US$ Million) Figure 58. North America Liganlong Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Liganlong Granules Revenue (2021-2032) & (US$ Million) Figure 60. Europe Liganlong Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Liganlong Granules Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Liganlong Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Liganlong Granules Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Liganlong Granules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Liganlong Granules Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Liganlong Granules Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 5g
  • 10g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Zhongjing Wanxi Pharmaceutical Co., Ltd.
  • Tibet Tibetan Medicine Group Co., Ltd.
  • Sichuan Luye Pharmaceutical Co., Ltd.
  • Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  • Liaoning Keji Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  • Jilin Yatai Pharmaceutical Co., Ltd.
  • Jilin Yinoke Pharmaceutical Co., Ltd.
  • Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  • Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  • Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  • Hainan Zhongbao Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Guizhou Dalong Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  • Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  • Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  • Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  • Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  • Dalian Hanfang Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Liganlong Granules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Liganlong Granules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Liganlong Granules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Liganlong Granules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Liganlong Granules Market Dynamics
  1. 2.1 Liganlong Granules Industry Trends
  2. 2.2 Liganlong Granules Industry Drivers
  3. 2.3 Liganlong Granules Industry Opportunities and Challenges
  4. 2.4 Liganlong Granules Industry Restraints
3 Liganlong Granules Market by Manufacturers
  1. 3.1 Global Liganlong Granules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Liganlong Granules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Liganlong Granules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Liganlong Granules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Liganlong Granules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Liganlong Granules Manufacturers, Product Type & Application
  7. 3.7 Global Liganlong Granules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Liganlong Granules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Liganlong Granules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Liganlong Granules Tier 1, Tier 2, and Tier 3
4 Liganlong Granules Market by Type
  1. 4.1 Liganlong Granules Type Introduction
  2. 4.1.1 5g
  3. 4.1.2 10g
  4. 4.2 Global Liganlong Granules Sales by Type
  5. 4.2.1 Global Liganlong Granules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Liganlong Granules Sales by Type (2021-2032)
  7. 4.2.3 Global Liganlong Granules Sales Market Share by Type (2021-2032)
  8. 4.3 Global Liganlong Granules Revenue by Type
  9. 4.3.1 Global Liganlong Granules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Liganlong Granules Revenue by Type (2021-2032)
  11. 4.3.3 Global Liganlong Granules Revenue Market Share by Type (2021-2032)
5 Liganlong Granules Market by Application
  1. 5.1 Liganlong Granules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Liganlong Granules Sales by Application
  6. 5.2.1 Global Liganlong Granules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liganlong Granules Sales by Application (2021-2032)
  8. 5.2.3 Global Liganlong Granules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Liganlong Granules Revenue by Application
  10. 5.3.1 Global Liganlong Granules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Liganlong Granules Revenue by Application (2021-2032)
  12. 5.3.3 Global Liganlong Granules Revenue Market Share by Application (2021-2032)
6 Global Liganlong Granules Sales by Region
  1. 6.1 Global Liganlong Granules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liganlong Granules Sales by Region (2021-2032)
  3. 6.2.1 Global Liganlong Granules Sales by Region (2021-2026)
  4. 6.2.2 Global Liganlong Granules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Liganlong Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Liganlong Granules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Liganlong Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Liganlong Granules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Liganlong Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Liganlong Granules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Liganlong Granules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Liganlong Granules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Liganlong Granules Revenue by Region
  1. 7.1 Global Liganlong Granules Revenue by Region
  2. 7.1.1 Global Liganlong Granules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Liganlong Granules Revenue by Region (2021-2026)
  4. 7.1.3 Global Liganlong Granules Revenue by Region (2027-2032)
  5. 7.1.4 Global Liganlong Granules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Liganlong Granules Revenue (2021-2032)
  8. 7.2.2 North America Liganlong Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Liganlong Granules Revenue (2021-2032)
  11. 7.3.2 Europe Liganlong Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Liganlong Granules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Liganlong Granules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Liganlong Granules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Liganlong Granules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhongjing Wanxi Pharmaceutical Co., Ltd.
  2. 8.1.1 Zhongjing Wanxi Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Zhongjing Wanxi Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhongjing Wanxi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  6. 8.1.5 Zhongjing Wanxi Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Tibet Tibetan Medicine Group Co., Ltd.
  8. 8.2.1 Tibet Tibetan Medicine Group Co., Ltd. Company Information
  9. 8.2.2 Tibet Tibetan Medicine Group Co., Ltd. Business Overview
  10. 8.2.3 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Tibet Tibetan Medicine Group Co., Ltd. Liganlong Granules Product Portfolio
  12. 8.2.5 Tibet Tibetan Medicine Group Co., Ltd. Recent Developments
  13. 8.3 Sichuan Luye Pharmaceutical Co., Ltd.
  14. 8.3.1 Sichuan Luye Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Sichuan Luye Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Luye Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  18. 8.3.5 Sichuan Luye Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd.
  20. 8.4.1 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  24. 8.4.5 Liaoning Wohua Kangchen Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Liaoning Keji Pharmaceutical Co., Ltd.
  26. 8.5.1 Liaoning Keji Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Liaoning Keji Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Liaoning Keji Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  30. 8.5.5 Liaoning Keji Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Liaoning Dongyi Pharmaceutical Co., Ltd.
  32. 8.6.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  36. 8.6.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Jiangxi Chuanqi Pharmaceutical Co., Ltd.
  38. 8.7.1 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  42. 8.7.5 Jiangxi Chuanqi Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Jilin Yatai Pharmaceutical Co., Ltd.
  44. 8.8.1 Jilin Yatai Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Jilin Yatai Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jilin Yatai Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  48. 8.8.5 Jilin Yatai Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jilin Yinoke Pharmaceutical Co., Ltd.
  50. 8.9.1 Jilin Yinoke Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jilin Yinoke Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jilin Yinoke Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  54. 8.9.5 Jilin Yinoke Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Jilin Aodong Yanbian Pharmaceutical Co., Ltd.
  56. 8.10.1 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  60. 8.10.5 Jilin Aodong Yanbian Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Heilongjiang Tianhong Pharmaceutical Co., Ltd.
  62. 8.11.1 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  66. 8.11.5 Heilongjiang Tianhong Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd.
  68. 8.12.1 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  72. 8.12.5 Heilongjiang Sinopharm Shuanglanxing Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Hainan Zhongbao Pharmaceutical Co., Ltd.
  74. 8.13.1 Hainan Zhongbao Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Hainan Zhongbao Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hainan Zhongbao Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  78. 8.13.5 Hainan Zhongbao Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  80. 8.14.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  84. 8.14.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Guizhou Dalong Pharmaceutical Co., Ltd.
  86. 8.15.1 Guizhou Dalong Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Guizhou Dalong Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Guizhou Dalong Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  90. 8.15.5 Guizhou Dalong Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
  92. 8.16.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  96. 8.16.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Guangxi Xiuzhen Pharmaceutical Co., Ltd.
  98. 8.17.1 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  102. 8.17.5 Guangxi Xiuzhen Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
  104. 8.18.1 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  108. 8.18.5 Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd.
  110. 8.19.1 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Company Information
  111. 8.19.2 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Business Overview
  112. 8.19.3 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Liganlong Granules Product Portfolio
  114. 8.19.5 Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. Recent Developments
  115. 8.20 Dalian Meiluo Chinese Medicine Factory Co., Ltd.
  116. 8.20.1 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Company Information
  117. 8.20.2 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Business Overview
  118. 8.20.3 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Liganlong Granules Product Portfolio
  120. 8.20.5 Dalian Meiluo Chinese Medicine Factory Co., Ltd. Recent Developments
  121. 8.21 Dalian Hanfang Pharmaceutical Co., Ltd.
  122. 8.21.1 Dalian Hanfang Pharmaceutical Co., Ltd. Company Information
  123. 8.21.2 Dalian Hanfang Pharmaceutical Co., Ltd. Business Overview
  124. 8.21.3 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Dalian Hanfang Pharmaceutical Co., Ltd. Liganlong Granules Product Portfolio
  126. 8.21.5 Dalian Hanfang Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Liganlong Granules Value Chain Analysis
  2. 9.1.1 Liganlong Granules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Liganlong Granules Production Mode & Process
  6. 9.2 Liganlong Granules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Liganlong Granules Distributors
  9. 9.2.3 Liganlong Granules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst